Collegeville, PA, United States of America

Xinrong Tian

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 6.3

ph-index = 6

Forward Citations = 116(Granted Patents)


Company Filing History:


Years Active: 2013-2020

where 'Filed Patents' based on already Granted Patents

15 patents (USPTO):

Title: **Inventor Xinrong Tian: Pioneering Innovations in Cancer Therapy**

Introduction

Xinrong Tian, based in Collegeville, Pennsylvania, is a prominent inventor recognized for his significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 15 patents, Tian has focused primarily on inhibitors related to Enhancer of Zeste Homolog 2 (EZH2), which play a critical role in cancer treatment.

Latest Patents

Among his latest inventions, Tian has developed novel compounds that serve as inhibitors of Enhancer of Zeste Homolog 2 (EZH2). His first notable patent outlines compounds represented by Formula (I), which not only act as inhibitors but are also formulated for therapeutic use against various cancers. Another patent expands on this concept with compounds described in Formula (III)(a), further enhancing the pharmaceutical options available for treating malignancies. These inventions represent crucial steps forward in cancer therapeutics, showcasing Tian's commitment to advancing medical science.

Career Highlights

Throughout his career, Xinrong Tian has collaborated with leading pharmaceutical firms, most notably GlaxoSmithKline LLC and GlaxoSmithKline Intellectual Property Limited. His work in these institutions has enabled him to apply his innovative ideas and contribute substantially to drug development efforts aimed at combating cancer.

Collaborations

In the realm of research and development, Tian has partnered with esteemed colleagues such as William Henry Miller and Neil W. Johnson. These collaborations have fostered a creative environment conducive to groundbreaking discoveries and the advancement of cancer therapies.

Conclusion

Xinrong Tian stands out as a significant figure in the field of cancer research, with his numerous patents and partnerships highlighting his dedication to innovation. His work continues to inspire future developments in cancer treatment, making a lasting impact on both the scientific community and patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…